Yan Zhou

Yan Zhou

Auto-generated profile, based on publicly available information

Yan Zhou

Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2007 in Personality and Individual Differences
Verified
Journal Article
Closed access
YGYiqun Gan
Yiqun Gan
MYManshu Yang
Manshu Yang
YZYan Zhou
Yan Zhou
YZYiling Zhang
Yiling Zhang

14 October 2016 in Alzheimer's & Dementia: Translational Research & Clinical Interventions
Verified
Journal Article
Open access
YZYan Zhou
Yan Zhou
DEDavid Elashoff
David Elashoff
SKSarah Kremen
Sarah Kremen
ETEdmond Teng
Edmond Teng
JKJason Karlawish
Jason Karlawish
JGJoshua D. Grill
Joshua D. Grill
Introduction: Alzheimer's disease (AD) incidence is disproportionately high in African Americans, yet, recruitment of this community to AD clinical trials is challenging. Methods: We compared 47 African Americans and 78 whites in their willingness to enroll in a hypothetical preclinical AD trial and examined barriers and facilitators in their decision making. Results: African American race (OR = 0.45; 95% CI, 0.22–0.93) and score on the research attitude questionnaire (OR = 1.12; 95% CI, 1.04–1.22) were independently associated with willingness to participate. African Americans rated study risks, the requirement of a study partner, study procedures, the ratio of drug to placebo, and study location as more important factors in the decision whether to enroll than did whites. Discussion: These results suggest that researchers will encounter challenges in recruiting African Americans to preclinical AD trials. Future research will be necessary to understand the optimal means to improve recruitment of underrepresented populations.

14 February 2015 in Brain
Verified
Journal Article
Open access
PDF file
JRJohn M. Ringman
John M. Ringman
LLLi-Jung Liang
Li-Jung Liang
YZYan Zhou
Yan Zhou
SVSitaram Vangala
Sitaram Vangala
ETEdmond Teng
Edmond Teng
TNThe Dominantly Inherited Alzheimer Network
The Dominantly Inherited Alzheimer Network
Prior studies indicate psychiatric symptoms such as depression, apathy and anxiety are risk factors for or prodromal symptoms of incipient Alzheimer’s disease. The study of persons at 50% risk for inheriting autosomal dominant Alzheimer’s disease mutations allows characterization of these symptoms before progressive decline in a population destined to develop illness. We sought to characterize early behavioural features in carriers of autosomal dominant Alzheimer’s disease mutations. Two hundred and sixty-one persons unaware of their mutation status enrolled in the Dominantly Inherited Alzheimer Network, a study of persons with or at-risk for autosomal dominant Alzheimer’s disease, were evaluated with the Neuropsychiatric Inventory-Questionnaire, the 15-item Geriatric Depression Scale and the Clinical Dementia Rating Scale (CDR). Ninety-seven asymptomatic (CDR = 0), 25 mildly symptomatic (CDR = 0.5), and 33 overtly affected (CDR > 0.5) autosomal dominant Alzheimer’s disease mutation carriers were compared to 106 non-carriers with regard to frequency of behavioural symptoms on the Neuropsychiatric Inventory-Questionnaire and severity of depressive symptoms on the Geriatric Depression Scale using generalized linear regression models with appropriate distributions and link functions. Results from the adjusted analyses indicated that depressive symptoms on the Neuropsychiatric Inventory-Questionnaire were less common in cognitively asymptomatic mutation carriers than in non-carriers (5% versus 17%, P = 0.014) and the odds of experiencing at least one behavioural sign in cognitively asymptomatic mutation carriers was lower than in non-carriers (odds ratio = 0.50, 95% confidence interval: 0.26–0.98, P = 0.042). Depression (56% versus 17%, P = 0.0003), apathy (40% versus 4%, P < 0.0001), disinhibition (16% versus 2%, P = 0.009), irritability (48% versus 9%, P = 0.0001), sleep changes (28% versus 7%, P = 0.003), and agitation (24% versus 6%, P = 0.008) were more common and the degree of self-rated depression more severe (mean Geriatric Depression Scale score of 2.8 versus 1.4, P = 0.006) in mildly symptomatic mutation carriers relative to non-carriers. Anxiety, appetite changes, delusions, and repetitive motor activity were additionally more common in overtly impaired mutation carriers. Similar to studies of late-onset Alzheimer’s disease, we demonstrated increased rates of depression, apathy, and other behavioural symptoms in the mildly symptomatic, prodromal phase of autosomal dominant Alzheimer’s disease that increased with disease severity. We did not identify any increased psychopathology in mutation carriers over non-carriers during the presymptomatic stage, suggesting these symptoms result when a threshold of neurodegeneration is reached rather than as life-long qualities. Unexpectedly, we found lower rates of depressive symptoms in cognitively asymptomatic mutation carriers.

1 July 2014 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
JRJohn M. Ringman
John M. Ringman
MSMichael C. Sachs
Michael C. Sachs
YZYan Zhou
Yan Zhou
SMSarah E. Monsell
Sarah E. Monsell
JSJeffrey L Saver
Jeffrey L Saver
HVHarry V. Vinters
Harry V. Vinters
The prevalence of cerebral amyloid angiopathy (CAA) increases with age, being found in the brain of 36% of individuals older than 60 years and 46% of those older than 70 years.1 It is more common in persons dying with dementia, being present in 55% to 59%,2 and occurs in 80% of those with concurrent Alzheimer disease (AD) pathology.3 In addition to possibly contributing independently to cognitive dysfunction,4,5 CAA is associated with an increased risk of spontaneous6 and anticoagulant-related7 intracerebral hemorrhage (ICH). It is also associated with a higher risk of vascular complications of antiamyloid therapies being used to treat AD.8 Although CAA currently remains a diagnosis only made definitively by biopsy or autopsy, its clinical implications during life are increasingly evident.

17 September 2014 in Psychometrika
Verified
Journal Article
Closed access
PDF file
YZYan Zhou
Yan Zhou
JMJohn J. McArdle
John J. McArdle
Classification and Regression Trees (CART), and their successors—bagging and random forests, are statistical learning tools that are receiving increasing attention. However, due to characteristics of censored data collection, standard CART algorithms are not immediately transferable to the context of survival analysis. Questions about the occurrence and timing of events arise throughout psychological and behavioral sciences, especially in longitudinal studies. The prediction power and other key features of tree-based methods are promising in studies where an event occurrence is the outcome of interest. This article reviews existing tree algorithms designed specifically for censored responses as well as recently developed survival ensemble methods, and introduces available computer software. Through simulations and a practical example, merits and limitations of these methods are discussed. Suggestions are provided for practical use.

6 March 2015 in Dementia and Geriatric Cognitive Disorders Extra
Verified
Journal Article
Open access
PDF file
YZYan Zhou
Yan Zhou
FOFreddy Ortiz
Freddy Ortiz
CNChristopher Nuñez
Christopher Nuñez
DEDavid Elashoff
David Elashoff
EWEllen Woo
Ellen Woo
JRJohn M. Ringman
John M. Ringman
Background/Aims: Performance on the Montreal Cognitive Assessment (MoCA) has been demonstrated to be dependent on the educational level. The purpose of this study was to identify how to best adjust MoCA scores and to identify MoCA items most sensitive to cognitive decline in incipient Alzheimer's disease (AD) in a Spanish-speaking population with varied levels of education. Methods: We analyzed data from 50 Spanish-speaking participants. We examined the pattern of diagnosis-adjusted MoCA residuals in relation to education and compared four alternative score adjustments using bootstrap sampling. Sensitivity and specificity analyses were performed for the raw and each adjusted score. The interval reliability of the MoCA as well as item discrimination and item validity were examined. Results: We found that with progressive compensation added for those with lower education, unexplained residuals decreased and education-residual association moved to zero, suggesting that more compensation was necessary to better adjust MoCA scores in those with a lower educational level. Cube copying, sentence repetition, delayed recall, and orientation were most sensitive to cognitive impairment due to AD. Conclusion: A compensation of 3-4 points was needed for <6 years of education. Overall, the Spanish version of the MoCA maintained adequate psychometric properties in this population.